
🧵 How should we choose reduced-intensity conditioning for older patients with AML/MDS undergoing allogeneic transplant? Our new @BloodPortfolio study uses @CIBMTR data from >11,000 patients to compare 5 commonly used RIC/NMA regimens. | @fredhutch 🔗 doi.org/10.1182/blood.202603…
















